Boston Scientific is proud to be recognized by Clarivate Analytics as one of the Top 100 Global Innovators. The list honors the most innovative corporations and institutions in the world determined by analyzing proprietary data.
“Meaningful innovation is a cornerstone of what we do at Boston Scientific,” said Dave Knapp, vice president, Corporate Research. “We invest over $800 million in R&D and clinical science each year so that we can continue to develop new treatments that help patients live longer.”
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, Boston Scientific provides a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. In 2015 alone, Boston Scientific launched 75 new products and reinvested 11.7 percent of sales in R&D and the company has achieved 16,000 patents globally.